Future longitudinal studies of PWH before development of TB will be important to determine whether increased expression of HLA-DR, CD38, and Ki67 can be leveraged as a biomarker to facilitate identification of individuals in the early phases of Mtb reactivation and TB progression to prioritize TB testing and initiation of treatment. The gene discussed is CD38; the disease is tuberculosis.